Zentek Engages Atrium Research Corporation For Company-Sponsored Research Coverage
Rhea-AI Summary
Zentek (NASDAQ: ZTEK; TSXV: ZEN) has engaged Atrium Research Corporation, a company-sponsored research firm, to provide ongoing research coverage. Atrium will produce reports based on public information, industry data and management discussions, and will host two recorded interviews with Zentek’s management on its business and strategy.
Atrium will receive cash compensation of $13,200 per quarter for an initial 18‑month term starting July 15, 2026, after which the agreement may continue quarter‑to‑quarter at the same rate, subject to TSXV approval. Zentek highlights that Atrium is at arm’s length and holds no securities. Management notes the coverage will address the Albany Graphite Project, now advancing toward a Preliminary Economic Assessment targeted for completion this summer, and the ZenGUARD air filtration platform, which is already generating commercial revenue.
Positive
- None.
Negative
- None.
News Market Reaction – ZTEK
In the Jul 15 session, ZTEK gained 6.50%, reflecting a notable positive market reaction. Argus tracked a peak move of +6.5% during that session. Argus tracked a trough of -5.1% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 07 | Commercial order win | Positive | +10.7% | First U.S. commercial order for ZenGUARD air filtration media from Quality Filters. |
| Jun 29 | U.S. sales pathway | Positive | -5.7% | Exclusive U.S. license enabling ZenGUARD media sales with EPA-registered silver technology. |
| Jun 26 | Graphite JV formation | Positive | +25.6% | Strategic Graphite Partners JV to position Albany graphite in U.S. security supply chains. |
| Jun 09 | U.S. patent grant | Positive | -3.8% | Grant of U.S. patent for ZenGUARD graphene-based technology with extended patent term. |
| May 13 | Government procurement access | Positive | +16.5% | ZenGUARD Enhanced Air Filters added to Canada’s Pathway to Commercialization source list. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent Zentek news has often triggered sizable moves, with positive commercialization and partnership updates sometimes followed by double-digit percentage reactions in both directions.
Key Terms
preliminary economic assessment technical
nuclear-grade technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company-sponsored research coverage to broaden Zentek's visibility with the global investment community
Guelph, Ontario--(Newsfile Corp. - July 15, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that it has engaged Atrium Research Corporation ("Atrium"), a company-sponsored research firm, to provide research coverage of the Company.
Atrium will publish research reports on Zentek based on publicly available information, industry data, and discussions with management. Atrium will also host two recorded interviews with Zentek's management team to discuss the Company's business and strategy. In exchange for its research services, Atrium will receive cash compensation of
Atrium and the Company are arm's-length parties, and neither Atrium nor its insiders holds any shares or options to purchase shares in the issued and outstanding capital of the Company.
Management Commentary
"Atrium's research coverage will provide investors with in-depth analysis of Zentek's business, including the Albany Graphite Project, which is currently advancing through a Preliminary Economic Assessment targeted for completion this summer, and ZenGUARD™, our air filtration technology platform, which is already generating commercial revenue. Albany graphite has been purified at bench scale to 5N, consistent with nuclear-grade specifications and defence markets that require that level of purity. As the PEA is completed and we advance our other initiatives, we believe access to well-researched coverage will help investors evaluate the Company," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek.
About Zentek
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. Core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the principal critical minerals asset, advancing toward a PEA targeted for completion in summer 2026.
About Albany Graphite
The Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted in collaboration with American Energy Technologies Company, as previously disclosed by the Company on September 22, 2025, confirmed ultra-high purity of
About Atrium Research
Atrium Research provides institutional-quality, company-sponsored research on public equities in North America. Its investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Its research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, and in-depth valuation analysis. Atrium Research is wholly owned and operated by its co-founders, Ben Pirie and Nicholas Cortellucci.
For more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.com
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305193